ESE. K. Saribekyan

E. K. Saribekyan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


E. K. Saribekyan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sentinel lymph node biopsy in breast carcinoma in situ

    by I.M. Onofriychuk, A.D. Zikiryahodzhaev, E.K. Saribekyan, S.I. Mikhailov, V.S. Surkova, N.N. Volchenko, V.D. Oleynikova

    Due to the rapid development of breast cancer screening and its detection more often in earlier stages, preinvasive forms of breast cancer account for up to 20% of all forms of malignant neoplasms of the breast. Therefore, today in the treatment of breast cancer with ductal carcinoma in situ (DCIS) there is a tendency to de-escalate surgical intervention. This article reviews the literature, as well as current domestic and international clinical guidelines for the treatment of DCIS in order to study the frequency of detection of metastatic lesions during sentinel lymph node examination (SLNB), and assesses the feasibility and indications for SLNB. The findings of the current review article can supplement the existing data on the indications for SLNB in patients with DCIS and help clarify the recommendations for the treatment of ductal carcinoma in situ (DCIS).


  • Fertility preservation in women with BRCA1/2‑related cancers: contemporary strategies, international recommendations, and a multidisciplinary approach

    by S. I. Mikhailov, E. G. Novikova, D. Sh. Dzhabrailova, I. M. Onofriychuk, E. K. Saribekian, A. S. Zolotukhina, M. A. Revkova, P. A. Shatalov, K. V. Maksimov, N. V. Ablitsovа, et al.

    Inherited mutations in the BRCA1/BRCA2 genes significantly increase the risk of breast and ovarian cancer in women of reproductive age, posing a clinical and socioeconomic challenge due to loss of fertility during cancer treatment and preventive interventions. The expansion of genetic testing programs is shifting the focus to proactive management of reproductive potential, requiring the integration of oncology, reproductive medicine, and medical genetics. The novelty of this review lies in its comprehensive synthesis of data on the impact of treatment and prevention of BRCA-associated cancer on fertility and a critical assessment of the effectiveness of fertility preservation strategies. Purpose of the study . To summarize and analyze current advances, clinical guidelines, and unresolved issues related to preserving reproductive function in women carrying BRCA1/BRCA2 mutations. Materials and methods . A systematic search of PubMed/MEDLINE, Embase, the Cochrane Library, and Web of Science was performed, along with an analysis of international guidelines (ESHRE (European Society of Human Reproduction and Embryology), ASCO (American Society of Clinical Oncology), ASRM (American Society for Reproductive Medicine), NCCN (National Comprehensive Cancer Network), ESMO (European Society for Medical Oncology)). Keywords: “BRCA1,” “BRCA2,” “fertility preservation,” “oocyte cryopreservation,” “embryo cryopreservation,” “ovarian tissue cryopreservation,” “PGT-M,” “PARP inhibitors,” and “chemotherapy gonadotoxicity.”, in the period of 2005–2025. Studies with incomplete data, duplicates, reviews of low methodological quality, and case series with fewer than 10 observations were excluded. Priority was given to meta-analyses, RCTs, large cohorts, and consensus reports. Results. The included studies included cancer patients before and after treatment, BRCA carriers with and without prophylactic strategies, and IVF/ICSI cohorts with cryopreservation. Alkylating agents and taxanes have been shown to increase the risk of premature ovarian failure, while GnRH agonists partially reduce the risk of ovarian toxicity. The efficacy of oocyte and embryo cryopreservation in BRCA-positive women is comparable to the population-­based efficacy with optimized stimulation (GnRH antagonists, letrozole-­containing protocols). Ovarian tissue cryopreservation is applicable in urgently needed patients but requires oncoprotective assessment. PGT-M ensures the selection of mutation-free embryos. Multidisciplinary pathways improve the timelines of referrals and the completion rate of fertility preservation programs Conclusion. Early identification of BRCA-positive women and the integration of a gynecologic oncologist, reproductive specialist, and geneticist enable personalized strategy selection: gamete/embryo cryopreservation, ovarian tissue, pharmacoprotection, and PGT-M. Standardized stimulation protocols and therapy timing, long-term safety and fertility data, and economic access models are needed. Improvements in biotechnology and patient pathways improve reproductive outcomes and quality of life.

  • Open Access

    Rare Disease: Breast Desmoid-Type Fibromatosis.

    by I. M. Onofriychuk, A. D. Zikiryahodzhaev, S. I. Mikhailov, V. D. Oleynikova, G. M. Zapirov, S. B. Zapirova, A. M. Lavrova, N. N. Volchenko, E. K. Saribekyan

    The article presents a rare form of pathological neoplasms — breast desmoid type fibromatosis. There are etiology and pathogenesis of the disease, clinical and morphological features, diagnostics and tactics of treatment of the disease. Widely covered clinical examples from the practice of a surgeon-oncologist. Desmoid fibromatosis (DF) is an aggressive non-metastatic mesenchymal formation that arises from musculoponeurotic structures. DF accounts for 0.03 % to 0.1 % of solid tumors and 3 % of mesenchymal tumors. Among breast pathology, this neoplasm is even rarer (0.2 %). Due to the rarity of such pathology, clinicians are not always able to correctly interpret the diagnostic picture and recognize the disease. The etiology and pathogenesis of the disease are also not fully understood, and therefore there are no standards for the treatment of desmoid fibromatosis. Surgical treatment remains the main one. To reduce the frequency of recurrence of the disease, the surgeon needs to achieve clean edges of the resection. Radiation therapy, hormone therapy, targeted therapy, and chemotherapy may additionally be considered as an alternative type of treatment. When the clean edges of the resection are reached, strict dynamic monitoring of pa is considered as further treatment.

  • Palliative surgical treatment in patients with breast cancer

    by I. M. Onofriychuk, A. D. Zikiryahodzhaev, Sh. G. Khakimova, E. K. Saribekyan, G. M. Zapirov, G. G. Khakimova, A. S. Sukhotko

    Last many years breast cancer on a leading position in the structure of oncological pathology among the female population. Patients with metastatic breast cancer, as well as with the presence of tumors with incipient decay or bleeding, are currently considered as patients for complex palliative systemic treatment. The question of the expediency of performing an operation in such a pathology occurs quite often in the daily practice of an oncologist-surgeon. Of course, such life-threatening conditions as decaying breast tumors, bleeding from them, do not raise doubts about the urgency of providing palliative surgical treatment, which is often it is sanitation mastectomy. However, the need for a surgical stage of treatment in the complex palliative therapy of metastatic breast cancer raises many questions. The possibilities of treating metastatic breast cancer have expanded significantly due to the development of drug therapy regimens, up to treating it as a chronic disease. The success of drug breast cancer treatment gives a chance to prolong the life of patients for many years. Thus, in the process of long-term treatment of these patients, various situations arise that require an individual solution. Based on the results of studies, the authors conclude that the decision to remove the primary breast lesion in such patients should be individualized and based on the opinion of the oncologist-surgeon, chemotherapist and radiation therapist, taking into account the potential risk, as well as the subsequent quality of life. In addition, as it turned out, the surgical stage of treatment in such patients not only improves the subsequent quality of life, but also improves oncological indicators. This article discusses the indications and contraindications for performing palliative surgical treatment of patients with breast cancer, based on world studies and our own experience and a clinical study.


  • Open Access

    Choosing a breast reconstruction method when planning radiotherapy in breast cancer patients

    by I. M. Onofriychuk, A. D. Zikiryakhodzhaev, E. K. Saribekyan, D. R. Ortabaeva, M. Yu. Vlasova, T. S. Berestok

    The list of indications to adjuvant radiation therapy for breast cancer patients was extended in recent years, regardless of the type of reconstruction. Surgeons and radiologists have to choose the most appropriate sequence of reconstruction and to reduce the risk of complications. Radiotherapy is one of the main factors causing complications in patients undergoing breast reconstruction, and vice versa, the implant might hinder radiotherapy, preventing proper delivery of the required radiation dose. Both oncologists and radiologists try to reduce the incidence of complications, which is an important interdisciplinary aim. This article investigates international experience of well-known cancer centers and experience of the Department of Oncology and Reconstructive Breast and Skin Surgery, P.A. Herzen Moscow Oncology Research Institute, a branch of the National Medical Radiology Research Center, Ministry of Health of Russia. We analyzed the choice of the breast reconstruction method in patients undergoing radiotherapy after surgery and developed recommendations for choosing an optimal method of reconstructive surgery.

  • Open Access

    Cystic lymphangioma of the breast. First case in Russian clinical practice

    by A. D. Zikiryahodzhaev, E. K. Saribekyan, E. A. Rasskazova, D. R. Ortabaeva, D. R. Omarova, S. P. Prokopenko, N. S. Goeva

    In this article, we review of the existing literature on cystic lymphangiomas and report a case of cystic lymphangioma of the breast in an 83‑year-old patient. This case required differential diagnosis between infiltrative cancer and cystic lymphangioma of the breast. The patient has undergone surgery (tumor removal). No complications were observed.

  • Open Access

    Complications after simultaneous prepectoral breast reconstruction using polyurethane-coated implants in patients with breast cancer

    by M. Yu. Vlasova, A. D. Zikiryakhodzhaev, I. V. Reshetov, F. N. Usov, E. K. Saribekyan, I. M. Shirokikh, A. N. Gerasimov, Sh. G. Khakimova, M. V. Starkova, N. V. Ablitsova, et al.

    Background. The development and improvement of reconstructive breast surgery provides medical, psychological and social rehabilitation of cancer patients, allowing them to achieve the best cosmetic and functional results. The trend towards the return of prepectoral reconstruction is associated not only with the improvement of mastectomy techniques, but also with implant coating and the emergence of highly cohesive silicone gel filling of implants. The use of polyurethane-coated endoprostheses in prepectoral reconstruction provides more reliable fixation to the surrounding tissues and allows reconstruction of the mammary glands without additional covering of the endoprosthesis.Objective: to improve the results of surgical treatment when performing a one-stage reconstruction by pre-rectal placement of polyurethanecoated implants in breast cancer. Materials and methods. In the period from April 2017 to September 2020 at the Department of Oncology and Reconstructive Plastic Surgery of the Breast and Skin of P.A. Herzen Moscow Oncology Research Institute performed 340 prepectoral breast reconstructions (direct-toimplant) using polyurethane-coated implants in breast cancer patients. A group of patients was analyzed (n = 208).Results. We noted the following complications: prolonged seroma (more than 30 days) in 39 (18.6 %) patients, red breast syndrome in 31 (14.8 %) patients, capsular contracture III–IV degree by J.L. Baker in 43 (20.57 %) patients, protrusion/extrusion of the endoprosthesis in 23 (11 %) patients, suture divergence in 8 (3.8 %) patients, necrosis in 8 (3.8 %) patients, infectious complications in 14 (6.7 %) patients, ripping in 10 (4.8 %) patients. Also, 2 (0.95 %) patients had a violation of the integrity of the endoprosthesis, and 2 (0.95 %) patients had rotation of the endoprosthesis. Conclusions. Prepectoral breast reconstruction can be used as an alternative to subpectoral reconstruction in primary operable forms of breast cancer with sufficient thickness of integumentary tissues.


  • Open Access

    Prepectoral reconstruction with polyurethane-coated implant after skin-sparing mastectomy in patients with breast cancer

    by M. Yu. Vlasova, A. D. Zikiryakhodzhaev, I. V. Reshetov, A. S. Sukhotko, E. K. Saribekyan, F. N. Usov, I. M. Shirokikh, T. S. Berestok, A. V. Tregubova

    Breast cancer is one of the most frequently diagnosed malignancies in the Russian Federation (RF), accounting for 20.9% of the female population in Russia. The surgery remains the primary treatment for breast cancer. Development and improvement of various options for reconstructive plastic surgery provides medical, psychological and social rehabilitation in patients with breast cancer, allows to achieve the best aesthetic and functional results. The possibility of performing such operations contributes to improving the quality of life of patients. According to ASPS (American Society of Plastic Surgeons), 80% of breast cancer reconstructions in the world are performed using silicone implants. Currently, the return of prepectoral space for placement of endoprostheses during breast reconstruction is trending, which is associated not only with the improvement of mastectomy techniques, but also with the coating of implants and the appearance of silicone highly adhesive gel filling of implants. According to the world literature data, the use of polyurethane-coated endoprostheses for prepectoral/subcutaneous reconstruction reduces the risk of capsular contracture, provides a more reliable fixation to the surrounding tissues, and thus allows breast reconstruction without the need for additional cover of the endoprosthesis. The use of the prepectoral space is characterized by a simpler operation technique compared to the retromuscular placement of the implant, the absence of damage to the large pectoral muscle, minimization of pain, reduction of the bed-day in the hospital and a faster rehabilitation period. So, this type of breast reconstruction can be considered as an alternative to submuscular implant placement in primary operable forms of breast cancer with sufficient thickness of the integumentary tissues.


  • Open Access

    Amelanotic melanoma and pyogenic granuloma. Peculiarities of the differential diagnosis

    by Azizzhon D. Zikiryachodzhaev, E. K. Saribekyan, E. Yu. Vertieva, I. S. Pestin

    INTRODUCTION:Nodular melanoma is a rapidly progressive skin tumour with a high risk of methastasis even on early stages. This fact leads to necessity of non-invasive procedures, which can verify this diagnosis before surgery. Nodular forms of amelanotic melanoma can be hardly diagnosed because of their unusual diagnostic and dermatoscopic features. CASE REPORT:Pyogenic granuloma is the most difficult disease for differential diagnosis. It is a benign vascular formation, which mimics nodular amelanotic melanoma.


  • Open Access

    BIOLOGICAL AND SYNTHETIC MATERIALS IN RECONSTRUCTIVE SURGERY FOR BREAST CANCER TREATMENT (LITERATURE REVIEW)

    by A. D. Zikiryakhodzhaev, I. M. Shirokikh, N. V. Ablitsova, M. V. Ermoshchenkova, N. V. Kharchenko, E. K. Saribekyan, A. Yu. Tukmakov, A. S. Sukhot’kO, G. M. Zapirov, Sh. G. Khakimova

    During the last years has been a worldwide trend towards rejuvenating breast cancer, and the evolution of reconstructive breast surgery is proceeding at a rapid pace. The surgical method is the primary method in the combined and complex treatment of breast cancer, and radical mastectomy is still the main option for surgical treatment in most Russian clinics. Most women who need a mastectomy prefer a one-stage breast reconstruction, because the woman is quickly rehabilitated psychologically and physically after this operation. Nevertheless, the use of silicone endoprostheses did not solve the problems of breast reconstruction in combined treatment in oncology. The issue remains unresolved of various complications, related not only to infections, but also to the development of capsular contracture after radiotherapy. Many patients with a one-stage breast reconstruction using a silicone endoprostheses lack the volume of their own tissues for reliable shelter of the endoprosthesis. In such cases, synthetic reticulated implants, biological implants or autologous flaps are used to cover and strengthen the lower slope of the reconstructed breast.